Know Cancer

or
forgot password

UMCC 2-48 Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage


N/A
18 Years
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

UMCC 2-48 Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage


Inclusion Criteria:



1. 18 years of age

2. biopsy-proven unilateral invasive breast cancer of any histology or ductal carcinoma
in situ

3. patient desires or requires treatment with mastectomy

4. any patient who has undergone prior excisional biopsy of their primary breast tumor
must have had margins positive for disease, or must have either mammographic or
ultrasonographic evidence of probable residual disease in the breast.

5. patients receiving induction chemotherapy remain eligible for participation in the
study regardless of tumor response; those with a clinical complete response remain
eligible.

6. voluntarily signed informed consent. -

Exclusion Criteria:

1. male gender

2. lobular carcinoma in situ as the only cancerous histology

3. prior margin-negative excisional biopsy of primary breast tumor, with no evidence of
residual disease

4. patient being treated with breast conservation therapy inability to understand the
nature of the procedure pregnancy and/or active lactation

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

Lisa Newman, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Michigan Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

UMCC 2-48

NCT ID:

NCT00156260

Start Date:

January 2003

Completion Date:

October 2008

Related Keywords:

  • Breast Cancer
  • Breast Neoplasms

Name

Location

University of Michigan Cancer CenterAnn Arbor, Michigan  48109